Intrinsic Value of S&P & Nasdaq Contact Us

scPharmaceuticals Inc. SCPH NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
45/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$13.00
+129.3%

Financial Health Score — SCPH

scPharmaceuticals Inc. (SCPH) has an overall financial health rating of C+ with a composite score of 0 out of 5.

This suggests the company faces some financial challenges worth monitoring. Rating as of 2025-10-06.

C+
Overall Rating
2025-10-06

Rating History

Date Rating DCF ROE ROA D/E P/E P/B
2025-10-06 C+ -/5 -/5 -/5 -/5 -/5 -/5
2025-10-03 C+ -/5 -/5 -/5 -/5 -/5 -/5
2025-10-02 C+ -/5 -/5 -/5 -/5 -/5 -/5
2025-10-01 C+ -/5 -/5 -/5 -/5 -/5 -/5
2025-09-30 C+ -/5 -/5 -/5 -/5 -/5 -/5
2025-09-29 C+ -/5 -/5 -/5 -/5 -/5 -/5
2025-09-26 C+ -/5 -/5 -/5 -/5 -/5 -/5
2025-09-25 C+ -/5 -/5 -/5 -/5 -/5 -/5
2025-09-24 C+ -/5 -/5 -/5 -/5 -/5 -/5
2025-09-23 C+ -/5 -/5 -/5 -/5 -/5 -/5
2025-09-22 C+ -/5 -/5 -/5 -/5 -/5 -/5
2025-09-19 C+ -/5 -/5 -/5 -/5 -/5 -/5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message